Predictive Oncology (POAI)

Overall impact
B (64)

Commentary

Predictive Oncology is a strong overall performer. With a 'B' rating of 64.2 for overall impact (72nd percentile compared to all companies), Predictive Oncology ranks 90th out of 155 industry peers, behind American Shared Hospital Services, Accuray, Avinger and 86 others, and ahead of Hologic, Adm Tronics Unlimited, Top Glove Corporation and 62 others. On top material causes for Predictive Oncology's industry (Healthcare Equipment), Predictive Oncology performs well in Reduced Waste (91.4 score), Conflict Free Mineral Production (96.0), Access to Affordable Healthcare (95.3) and 2 other causes where it received an 'A' score and performs poorly in Sustainable Use of Natural Resources (39.7 score), Reduced Green House Gas Emissions (14.7) and Technology Innovation (31.3).
Impact
Cause POAI
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2002
Employees
23
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Pa, United States
Share classes
POAI
Description
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Material causes
Ethos considers the following causes material for Predictive Oncology, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.